Bespoke promoters and enhancers, for any tissue, any organism.
At Annogen, our vision is a future where safe and effective advanced therapies are specifically expressed in the right tissues with no off-target effects. We believe that this can be achieved by bespoke promoters (genetic switches) and genomic expression sites.
Therefore, Annogen is on a mission towards becoming the leading expertise center for gene expression engineering in order to improve the safety and effectiveness of tomorrow's cell and gene therapies.
Annogen leverages its proprietary SuRE™ technology to identify regulatory DNA elements to be used for controlled (therapeutic) gene expression for gene & cell therapy, as well as for recombinant protein and virus production. In addition, we develop service projects based on our proprietary AIM™ technology to identify favorable gene insertions and their expression levels for more than 100,000 integrations in parallel. These approaches typically enable big improvements in any biomedical strategy involving the (over-) expression of genes.
Annogen was founded in 2017 by Dr. Joris van Arensbergen, who developed and published the SuRE™ technology as a post-doctoral fellow in the laboratory of Prof. Dr. Bas van Steensel at the world-renowned Netherlands Cancer Institute (NKI). Today, Annogen is the trusted partner for bespoke gene expression engineering for leading biopharmaceutical, agricultural and academic research centers globally.
Company Details
- Employees
- 10
- Founded
- -
- Address
- Science Park 406, Amsterdam,1098 Xh,netherlands
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- annogen.bio
- HQ
- Amsterdam
Annogen Questions
Annogen's website is annogen.bio
Annogen's LinkedIn profile is https://nl.linkedin.com/company/annogen-bv
Annogen has
10 employees.
View email and phone details for 10
employees at Annogen.
Annogen's industry is
Biotechnology Research
Annogen's top competitors are
Scenic Biotech,
Hubrecht Institute,
Solvias Nl (Formerly Cergentis),
Cradle,
Vectory,
Rainbow Crops,
Single Cell Discoveries,
Winclove Probiotics,
Genmab,
Inbiome.
Annogen's categories are Biotechnology Research
Annogen's founding year is 2017
